Related references
Note: Only part of the references are listed.RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability
Zhi-gang Huang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma
Zhilan Chai et al.
ACS NANO (2019)
Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
Fwu-Long Mi et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
Fwu-Long Mi et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Star-Graft Quarterpolymer-Based Polymersomes as Nanocarriers for Co-Delivery of Hydrophilic/Hydrophobic Chemotherapeutic Agents
Zacharoula Iatridi et al.
ACS OMEGA (2018)
In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
Min Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Albumin-coated nanocrystals for carrier-free delivery of paclitaxel
Joonyoung Park et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Exploring intracellular fate of drug nanocrystals with crystal-integrated and environment-sensitive fluorophores
Wei Gao et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Deposition and Adhesion of Polydopamine on the Surfaces of Varying Wettability
Chao Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer
Aaron Goldman et al.
ACS NANO (2016)
Impact of surfactant treatment of paclitaxel nanocrystals on biodistribution and tumor accumulation in tumor-bearing mice
Wei Gao et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
Sylvie Lorenzen et al.
EUROPEAN JOURNAL OF CANCER (2015)
A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel
Hongxiang Hu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
A Novel Combined Micellar System of Lapatinib and Paclitaxel with Enhanced Antineoplastic Effect Against Human Epidermal Growth Factor Receptor-2 Positive Breast Tumor In Vitro
Yan Wei et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study
Taroh Satoh et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Qi Yin et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Ameya R. Kirtane et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancer
Zhongzhen Guan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
Daniele Vergara et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Managing drug resistance in cancer: lessons from HIV therapy
Christoph Bock et al.
NATURE REVIEWS CANCER (2012)
Physical and chemical stability of drug nanoparticles
Libo Wu et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy
Ken Kato et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
State of the art of nanocrystals - Special features, production, nanotoxicology aspects and intracellular delivery
Rainer H. Mueller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer
Feng Li et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Combined lapatinib and paclitaxel in HER2-positive breast cancer
Carlos A. Castaneda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer
Henry L. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer
Angelo Di Leo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mussel-inspired surface chemistry for multifunctional coatings
Haeshin Lee et al.
SCIENCE (2007)
Single-molecule mechanics of mussel adhesion
Haeshin Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Protein bonding on biodegradable poly(L-lactide-co-caprolactone) membrane for esophageal tissue engineering
YB Zhu et al.
BIOMATERIALS (2006)
Nanosuspensions in drug delivery
BE Rabinow
NATURE REVIEWS DRUG DISCOVERY (2004)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
MB Polee et al.
BRITISH JOURNAL OF CANCER (2002)
Polyphosphoprotein from the adhesive pads of Mytilus edulis
JH Waite et al.
BIOCHEMISTRY (2001)
Share Paper
